Pfizer's stock, after facing post-pandemic market blues, is showing glimmers of a comeback. The stock recently logged a 4.10% ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Discover top dividend-growth stocks trading near 52-week lows, including Salesforce, with strong growth potential, healthy ...

Exelixis' STELLAR-303 trial shows zanzalintinib plus Tecentriq improved survival in colorectal cancer, with no new safety ...

Three months after the US Sofdra launch, prescriptions have exceeded Botanix Pharmaceuticals' expectations. What are they ...

For this list, we're looking at U.S. stocks only that trade on major exchanges, with market caps of at least $10 billion. The ...

Novo Nordisk shows strong fundamentals and long-term return potential despite valuation concerns and US pricing risks. Find ...

The launch of the FIBRE Consortium, which includes Lantheus Holdings (NasdaqGM:LNTH) collaborating with Pfizer and Lumina Pharmaceuticals, aims to improve treatment for fibrotic diseases using ...

As if Wall Street wasn't troubled enough, the market has been in turmoil across early June thanks to the resurgence of geopolitical unrest in the Middle East. Throw in continued uncertainty ...

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast of a dominant position in the lucrative oncology space. Oncology ...

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Real-time updates on SOLARA ACTIVE PHARMA SCIENCES share price. Check out the detailed analysis of the company in this live blog.